Endometriosis Blood Test Gets Key Patent | Australia News

Proteomics International just secured a major patent win in Australia for their groundbreaking endometriosis blood test, PromarkerEndo — a game-changer that could slash diagnosis time from years to minutes using just a simple blood sample. With IP protection now in place until 2041 and already granted patents in the U.S. and Japan, the company is poised for global expansion. Their exclusive deal with Healius, Australia’s largest pathology network, ensures rapid patient access. For millions of women suffering from this debilitating condition, this innovation could finally deliver faster, less invasive, and more accurate diagnosis — turning hope into reality. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/978caf4cd46c9ae3